You are here: Industry Insights > teva

News List

Teva Recalls Two Blood Pressure Medications drugs
December 03, 2018
All lots of amlodipine/valsartan and amlodipine/valsartan/hydrochlorothiazide combination blood pressure tablets have been recalled by Teva ....
Teva's EpiPen generic retails for same price as Mylan's own pharmafile
November 29, 2018
Israeli generics firm Teva has revealed the price tag of its generic version of Mylan’s EpiPen epinephrine auto-injector, and, at $300 wholesale for a pack of two,
Teva Announces Recall americanpharmaceuticalreview
November 29, 2018
Teva Pharmaceuticals has initiated a voluntary recall in the United States, to the patient level, of all lots of Amlodipine / Valsartan combination tablets and Amlodipine / Valsartan.....
Teva proposes to buy Mylan for $40.1 billion biospectrumasia
November 16, 2018
He added that Mylan's business is a natural fit with Teva and is highly complementary to it. Merging the two companies would not only deliver the greatest value
US court overturns J&J's Zytiga patent in combination with prednisone pharmafile
October 31, 2018
A court in New Jersey has invalidated Johnson & Johnson’s patent on the prostate cancer drug Zytiga when used in combination with the steroid prednisone. ...
Global CGRP Drug Market Expected to Reach USD 5 Billion by 2024 1℃
October 09, 2018
with 4 Anti-CGRP Antibodies Ranking Top 4 of the Market
US regulator approves Teva's migraine drug biospectrumasia
September 29, 2018
Teva's drug can also be given in three-month intervals in three consecutive injections
Teva secures FDA approval for migraine drug Ajovy pharmaceutical-technology
September 20, 2018
The US Food and Drug Administration (FDA) has granted approval to Teva Pharmaceutical Industries’ Ajovy (fremanezumab-vfrm) injection for the preventive treatment of migraine in adults.
Teva shares soar after migraine treatment Ajovy approval pharmafile
September 20, 2018
Shares in the Israeli pharma firm Teva soared on Sunday after the announcement that the US Food and Drug Administration (FDA)...
Teva’s anti-CGRP drug Ajovy cleared for migraine prevention pharmatimes
September 18, 2018
US regulators have approved Teva’s Ajovy for the preventative treatment of migraine in adults.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 14 15 Next page